Important Safety Information  |  Prescribing Information  |  Patient Information  |  For US Healthcare Professionals
This site is for US residents only.
Vertex GPS™: Guidance & Patient Support

Now approved to treat more people living with CF who have certain mutations

KALYDECO® is a prescription medicine used for the treatment of cystic fibrosis (CF) in patients age 2 years and older who have at least one mutation in their CF gene that is responsive to KALYDECO.

Talk to your doctor to learn if you have an indicated CF gene mutation.

It is not known if KALYDECO is safe and effective in children under 2 years of age.


F508del and 26 other mutations are not responsive to KALYDECO. Please click here for a complete list.